Searchable abstracts of presentations at key conferences in endocrinology

Endocrine Abstracts

Published by BioScientifica
Previous issue | Volume 11 | ECE2006 | Next issue

8th European Congress of Endocrinology incorporating the British Endocrine Societies

Poster Presentations

Bone

Table of contents
Next section
Clinical case reports

ea0011p1 | Bone

An audit of the role of Sestimibi imaging of the parathyroid glands in the management of parathyroid disease

ea0011p2 | Bone

Does adrenal function influence bone status in primary hyperparathyroidism? Preliminary results in a large series of patients at the time of the diagnosis

ea0011p3 | Bone

The effect of local radiotherapy on osteoprotegrin levels in patients with bone metastases

ea0011p4 | Bone

Clinical aspects of diabetic osteoarthropathy in type 1 and type 2 diabetes mellitus patients

ea0011p5 | Bone

Osteoporotic fractures in old subjects: role of functional and nutritional status and therapy effects during one year after fracture

ea0011p6 | Bone

Circulating osteoprotegerin and receptor activator of NF- κB ligand system in patients with beta-thalassemia major

ea0011p7 | Bone

The role of genetic individuality and phytoestrogens with minerals in prevention and treatment of Postmenopausal osteoporosis

ea0011p8 | Bone

Is there any combined influence of the N363S polymorphism in the glucocorticoid receptor gene and the BsmI polymorphism in the vitamin D receptor gene on the occurrence of glucocorticoid-induced osteoporosis in patients with bronchial asthma?

ea0011p9 | Bone

Bone mineral density in patients with type 1 diabetes

ea0011p10 | Bone

Thyroid hormone receptor alpha has a critical negative role in maintenance of the adult skeleton

ea0011p11 | Bone

PTH and phosphate circadian rhythms are altered in adult growth hormone deficient patients with low bone mineral density

ea0011p12 | Bone

Oral phosphate therapy used as an adjunct to growth hormone in adult growth hormone deficiency results in greater changes in bone mineral density compared with growth hormone replacement alone

ea0011p13 | Bone

Polymorphism in farnesil pirofosfato sintasi (FDPS) gene and relation with bone mineral density and response to aminobisfosfonate treatment

ea0011p14 | Bone

Do different generations of PTH assay induce different diagnosis in renal bone disease?

ea0011p15 | Bone

Management of primary hyperparathyroidism – are we following consensus guidelines?

ea0011p16 | Bone

Value of qualitative bone histology assessment in the evaluation of subjects with primary osteoporosis

ea0011p17 | Bone

Hearing impairment increases risk of bone fractures in women with Turner’s syndome

ea0011p18 | Bone

Evaluation of bone mineral density and markers of bone turnover in haemodialysis patients

ea0011p19 | Bone

The effect of ceramide on IGF-1 induced proliferation in growth plate chondrocytes

ea0011p20 | Bone

Treatment and follow up of primary hyperparathyroidism: 50 cases

ea0011p21 | Bone

Is there any relationship between the BsmI and FokI polymorphisms in the vitamin d receptor gene and bone mineral density in men?

ea0011p22 | Bone

Mutational Analysis of the PHEX gene in familial and sporadic cases of X-linked hypophosphatemia (XLH)

ea0011p23 | Bone

The reduction of bone mineral density in post-menopausal women with primary hyperparathyroidism is higher in the presence of concomitant GH hormone secretion impairment

ea0011p24 | Bone

Effect of melatonin on gene expression and mineralization in mouse osteoblast culture

ea0011p25 | Bone

Effects of growth hormone administration on parathyroid hormone sensitivity and bone mineral metabolism in established osteoporosis

ea0011p26 | Bone

Is 1 g of calcium and 800 IU of Vitamin D sufficient to replenish Vitamin D stores in postmenopausal women with low bone density?

ea0011p27 | Bone

Synergistic induction of osteoblastic local glucocorticoid metabolism by inflammatory cytokines and glucocorticoids: a novel mechanism for glucocorticoid-induced bone disease

ea0011p28 | Bone

Evidence for high prevalence of hormonal irregularities in male osteoporosis

ea0011p29 | Bone

Evaluation of bone markers and structure in subclinical Cushing’s syndrome

ea0011p30 | Bone

Asymptomatic primary hyperparathyroidism: preliminary results of a prospetive randomized study on the effect of parathyroidectomy

ea0011p31 | Bone

Brown tumors in a patient with gluten enteropathy and masked primary (or tertiary) hyperparathyroidism

ea0011p32 | Bone

Baseline characteristics of postmenopausal Greek women with osteoporosis who had inadequate clinical response to antiresorptive medications.

ea0011p33 | Bone

Effect of grape procyanidins on TNF alpha mRNA expression and cell DNA damage in MC3T3-E1 osteoblast-like cells in vitro

ea0011p34 | Bone

The effects of Dexamethasone and Dehydroepiandrosterone (DHEA) on cytokines and receptor expression in a human osteoblastic cell line: potential steroid-sparing role for DHEA

ea0011p35 | Bone

Assessment of bone health and body composition in Glasgow school children

ea0011p36 | Bone

Assessment of bone mineral density (BMD) in patients with adrenal incidentaloma (ai): comparison between dual-energy x-ray absorptiometry (DEXA) and quantitative ultrasonometry (QUS)

ea0011p37 | Bone

A comparative study of neck ultrasonography, sestamibi scan and parathyroid surgery findings

ea0011p38 | Bone

Glucocorticoid metabolism in mouse osteoblasts: a model for the effects of local glucocorticoid generation on bone

ea0011p39 | Bone

Long-term growth hormone (GH) replacement in GH deficient adults – favourable effect on bone and body composition

ea0011p40 | Bone

Does parathyroidectomy reduce the risk of fractures and renal stones? Results of a systematic review and meta analysis

ea0011p41 | Bone

Brown tumors in hyperparathyroidism may be mistaken for primitive bone neoplasia: report of two cases

ea0011p42 | Bone

The effect of once-weekly Risedronate on biochemical markers of bone turnover after three month of treatment

ea0011p43 | Bone

Quantitative ultrasound at the hand phalanges in patients with acromegaly

ea0011p44 | Bone

Selenium supplementation restores the antioxidative capacity and prevents cell damage in mesenchymal stem cells in vitro

ea0011p45 | Bone

Expression of the membrane-associated hormone-sensitive protein UO-44 in hMSC-TERT immortalized mesenchymal stem cells

ea0011p46 | Bone

The effect of once-weekly Risedronate on biochemical markers of bone turnover after three month of treatment

Published by BioScientifica

Endocrine Abstracts
ISSN 1470-3947 (print) | ISSN 1479-6848 (online)
© Bioscientifica 2025 | Privacy policy | Cookie settings

BiosciAbstracts

Bioscientifica Abstracts is the gateway to a series of products that provide a permanent, citable record of abstracts for biomedical and life science conferences.

Find out more